title: Salmeterol/fluticasone combination instead of indacaterol or vice-versa?
authors.affiliation: Respiratory Disease Unit, University of Modena and Reggio Emilia, Modena, Italy leonardo.fabbri@unimore.it.
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Fabbri
authors.affiliation: Hospital Clinic de Barcelona, CIBER en Enfermedades Respiratorias (CIBERES), Barcelona, Spain Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
authors.forename: Alvar
authors.initials: A
authors.lastname: Agusti
mesh_terms: D000420:Albuterol / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D015363:Quinolones / Q000627:therapeutic use*
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D007189:Indans; D015363:Quinolones; D000420:Albuterol